Cogent Biosciences Cash from Investing (TTM) Insights

Cogent Biosciences Inc (COGT)

6.02 +0.01 (+0.17%) USD | NASDAQ | Apr 26, 16:00

6.015 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-97.82M
September 30, 2023	-79.90M
June 30, 2023	-140.91M
March 31, 2023	-64.39M
December 31, 2022	-124.72M
September 30, 2022	-153.56M
June 30, 2022	-3.181M
March 31, 2022	-2.16M
December 31, 2021	-1.719M
September 30, 2021	-1.286M
June 30, 2021	8.297M
March 31, 2021	8.42M
December 31, 2020

Date	Value
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019	23.16M
September 30, 2019	38.17M
June 30, 2019	47.86M
March 31, 2019	-1.506M
December 31, 2018	-10.53M
September 30, 2018	-20.63M
June 30, 2018	-24.82M
March 31, 2018	20.33M
December 31, 2017	13.59M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-153.56M

Minimum

Sep 2022

47.86M

Maximum

Jun 2019

-36.25M

Average

-2.16M

Median

Mar 2022

Cash from Investing (TTM) Benchmarks